5-fluorodopa has been researched along with Parkinson Disease in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuriakose, R; Stoessl, AJ | 1 |
| Piccini, P; Politis, M | 1 |
| Abbs, JH; Bendlin, BB; Brooks, BR; Brown, WD; Chung, MK; Dejesus, OT; Dogan, S; Gallagher, CL; Holden, JE; Johnson, SC; Konopacki, RA; Nickles, RJ; Oakes, TR; Pyzalski, RW; Xu, G | 1 |
| Brooks, DJ; Burn, DJ; Duvoisin, RC; Harding, AE; Maraganore, DM; Mark, MH; Marsden, CD; Playford, ED; Zimmerman, TR | 1 |
| Heiss, WD; Herholz, K; Holthoff, V; Huber, M; Karbe, H; Wagner, R; Wienhard, K | 1 |
| Björklund, A; Bloomfield, PM; Brooks, DJ; Brundin, P; Leenders, KL; Lindvall, O; Marsden, CD; Rehncrona, S; Sawle, GV; Widner, H | 1 |
| Sawle, GV | 1 |
| Fujii, N; Goto, I; Hasuo, K; Hosokawa, S; Ichiya, Y; Kato, M; Kuwabara, Y; Otsuka, M; Taniwaki, T | 1 |
| Brundin, P; Frackowiak, R; Gustavii, B; Leenders, KL; Lindvall, O; Marsden, CD; Rehncrona, S; Rothwell, JC; Sawle, G; Widner, H | 1 |
| Clark, JC; Firnau, G; Garnett, ES; Jones, T; Leenders, KL; Marsden, CD; Nahmias, C; Palmer, AJ; Quinn, N | 1 |
| Martin, WR | 1 |
3 review(s) available for 5-fluorodopa and Parkinson Disease
| Article | Year |
|---|---|
Imaging the nigrostriatal system to monitor disease progression and treatment-induced complications.
Topics: Animals; Biomarkers; Cerebrovascular Circulation; Corpus Striatum; Dihydroxyphenylalanine; Disease Progression; Dopamine; Humans; Magnetic Resonance Imaging; Movement Disorders; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Substantia Nigra; Synapses; Tomography, Emission-Computed, Single-Photon | 2010 |
Brain imaging after neural transplantation.
Topics: Animals; Brain; Brain Tissue Transplantation; Cerebral Cortex; Clinical Trials as Topic; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dyskinesias; Fetal Tissue Transplantation; Graft Survival; Humans; Nerve Net; Parkinson Disease; Positron-Emission Tomography; Receptors, Presynaptic; Tomography, Emission-Computed, Single-Photon | 2010 |
Positron emission tomography in movement disorders.
Topics: Brain; Cerebrovascular Circulation; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dystonia; Glucose; Humans; Huntington Disease; Levodopa; Movement Disorders; Oxygen Consumption; Parkinson Disease; Synapses; Tomography, Emission-Computed | 1985 |
8 other study(ies) available for 5-fluorodopa and Parkinson Disease
| Article | Year |
|---|---|
A longitudinal study of motor performance and striatal [18F]fluorodopa uptake in Parkinson's disease.
Topics: Aged; Aging; Antiparkinson Agents; Carbidopa; Caudate Nucleus; Corpus Striatum; Dihydroxyphenylalanine; Female; Hand Strength; Humans; Isometric Contraction; Levodopa; Longitudinal Studies; Male; Middle Aged; Muscle Strength; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Psychomotor Performance; Radiopharmaceuticals; Reaction Time; Retrospective Studies; Sex Characteristics; Tongue | 2011 |
Parkinson's disease in twins studied with 18F-dopa and positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Brain; Dihydroxyphenylalanine; Diseases in Twins; Fluorine Radioisotopes; Humans; Middle Aged; Parkinson Disease; Tissue Distribution; Tomography, Emission-Computed; Twins, Dizygotic; Twins, Monozygotic | 1992 |
Positron emission tomography in degenerative disorders of the dopaminergic system.
Topics: Adult; Aged; Alzheimer Disease; Basal Ganglia; Brain; Brain Stem; Deoxyglucose; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Middle Aged; Parietal Lobe; Parkinson Disease; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1992 |
Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Brain Tissue Transplantation; Caudate Nucleus; Dihydroxyphenylalanine; Dopamine; Fetal Tissue Transplantation; Humans; Mesencephalon; Models, Biological; Parkinson Disease; Parkinson Disease, Secondary; Putamen; Tomography, Emission-Computed | 1992 |
The rate of progression of Parkinson's disease.
Topics: Adult; Aged; Cell Death; Dihydroxyphenylalanine; Humans; Middle Aged; Parkinson Disease; Reproducibility of Results; Substantia Nigra; Tomography, Emission-Computed | 1992 |
Positron emission tomography (PET) in "pure akinesia".
Topics: Adult; Aged; Brain Chemistry; Dihydroxyphenylalanine; Dopamine; Female; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Movement Disorders; Parkinson Disease; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1992 |
Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease.
Topics: Brain; Cell Survival; Dihydroxyphenylalanine; Dopamine; Fetus; Fluorine Radioisotopes; Follow-Up Studies; Humans; Immunosuppression Therapy; Mesencephalon; Neurons; Parkinson Disease; Putamen; Tomography, Emission-Computed | 1990 |
Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography.
Topics: Adult; Aged; Brain; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Tomography, Emission-Computed | 1986 |